1-8 of 8
sf3b1 gene
Close
Sort by
Journal Articles

Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification

Clinical Trials & Observations
Inge van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, Stephan Hutter, Constance Baer, Martijn Heymans, Peter J. M. Valk, Wolfgang Kern, Claudia Haferlach, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Jacqueline Cloos, Torsten Haferlach
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3254–3265.
https://doi.org/10.1182/bloodadvances.2021004556
Published: 2021
Includes: Supplemental data
Journal Articles

Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax

Clinical Trials & Observations
Curtis A. Lachowiez, Sanam Loghavi, Ken Furudate, Guillermo Montalban-Bravo, Abhishek Maiti, Tapan Kadia, Naval Daver, Gautam Borthakur, Naveen Pemmaraju, Koji Sasaki, Yesid Alvarado, Musa Yilmaz, Nicholas J. Short, Kelly Chien, Maro Ohanian, Sherry Pierce, Keyur P. Patel, Elias Jabbour, Farhad Ravandi, Hagop M. Kantarjian, Guillermo Garcia-Manero, Koichi Takahashi, Marina Y. Konopleva, Courtney D. DiNardo
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2173–2183.
https://doi.org/10.1182/bloodadvances.2020004173
Published: 2021
Includes: Supplemental data
Journal Articles

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing

W. Brian Dalton, Eric Helmenstine, Lisa Pieterse, Bing Li, Christopher D. Gocke, Joshua Donaldson, Zhijian Xiao, Lukasz P. Gondek, Gabriel Ghiaur, Ivana Gojo, B. Douglas Smith, Mark J. Levis, Amy E. DeZern
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1192–1196.
https://doi.org/10.1182/bloodadvances.2019001127
Published: 2020
Includes: Supplemental data
Journal Articles

Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern

Gerbrig Berger, Mylene Gerritsen, Guoqiang Yi, Theresia N. Koorenhof-Scheele, Leonie I. Kroeze, Marian Stevens-Kroef, Kenichi Yoshida, Yuichi Shiraishi, Eva van den Berg, Hein Schepers, Geert Huls, André B. Mulder, Seishi Ogawa, Joost H. A. Martens, Joop H. Jansen, Edo Vellenga
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3111–3122.
https://doi.org/10.1182/bloodadvances.2019000518
Published: 2019
Includes: Supplemental data
Journal Articles

The splicing factor Sf3b1 regulates erythroid maturation and proliferation via TGFβ signaling in zebrafish

Adriana De La Garza, Rosannah C. Cameron, Varun Gupta, Ellen Fraint, Sara Nik, Teresa V. Bowman
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2093–2104.
https://doi.org/10.1182/bloodadvances.2018027714
Published: 2019
Includes: Supplemental data
Journal Articles

A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes

Clinical Trials & Observations
Chi-Yuan Yao, Ching-Hsuan Chen, Huai-Hsuan Huang, Hsin-An Hou, Chien-Chin Lin, Mei-Hsuan Tseng, Chein-Jun Kao, Tzu-Pin Lu, Wen-Chien Chou, Hwei-Fang Tien
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1505–1516.
https://doi.org/10.1182/bloodadvances.2017008284
Published: 2017
Includes: Supplemental data
Journal Articles

Novel SF3B1 in-frame deletions result in aberrant RNA splicing in CLL patients

Clinical Trials & Observations
Anant A. Agrawal, Michael Seiler, Lindsey T. Brinton, Rose Mantel, Rosa Lapalombella, Jennifer A. Woyach, Amy J. Johnson, Ping Zhu, Markus Warmuth, Lihua Yu, John C. Byrd, Peter G. Smith, James S. Blachly, Silvia Buonamici
Journal: Blood Advances
Blood Adv (2017) 1 (15): 995–1000.
https://doi.org/10.1182/bloodadvances.2017007062
Published: 2017
Includes: Supplemental data
Journal Articles

Targeted deep sequencing in polycythemia vera and essential thrombocythemia

Clinical Trials & Observations
Ayalew Tefferi, Terra L. Lasho, Paola Guglielmelli, Christy M. Finke, Giada Rotunno, Yoseph Elala, Annalisa Pacilli, Curtis A. Hanson, Alessandro Pancrazzi, Rhett P. Ketterling, Carmela Mannarelli, Daniela Barraco, Tiziana Fanelli, Animesh Pardanani, Naseema Gangat, Alessandro M. Vannucchi
Journal: Blood Advances
Blood Adv (2016) 1 (1): 21–30.
https://doi.org/10.1182/bloodadvances.2016000216
Published: 2016
Includes: Supplemental data